Aisyah Noor
Stock Analyst at Morgan Stanley
(2.97)
# 2,681
Out of 5,058 analysts
130
Total ratings
49.3%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Aisyah Noor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: TECN Tecan Group AG | Reiterated: Hold | CHF 160.00 → CHF 178.00 | CHF 247.60 | -28.11% | 18 | Sep 11, 2026 | |
| EPA: BIM bioMérieux S.A. | Reiterated: Sell | €64.00 → €66.00 | €87.60 | -24.66% | 10 | Sep 11, 2026 | |
| BIT: DIA DiaSorin S.p.A. | Reiterated: Hold | €60.00 → €71.00 | €77.50 | -8.39% | 17 | Sep 11, 2026 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | €25.00 → €22.00 | €22.72 | -3.17% | 5 | Sep 11, 2026 | |
| QGEN Qiagen | Reiterated: Buy | $45 → $47 | $46.17 | +1.94% | 24 | Sep 11, 2026 | |
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 270p → 289p | 237p | +22.04% | 5 | Sep 2, 2026 | |
| LON: SN Smith & Nephew plc | Downgraded: Hold | 1,304p → 1,158p | 1,088p | +6.43% | 7 | Sep 2, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €49.00 → €52.00 | €43.86 | +18.57% | 6 | Aug 10, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 → €31.00 | €39.46 | -21.44% | 7 | Aug 5, 2026 | |
| SWX: STMN Straumann Holding AG | Reiterated: Sell | CHF 81.00 → CHF 85.00 | CHF 94.08 | -9.65% | 5 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | CHF 172.00 → CHF 205.00 | CHF 274.20 | -25.24% | 2 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €41.00 → €37.00 | €40.85 | -9.42% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 159.00 → CHF 161.00 | CHF 115.40 | n/a | 7 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | kr 182.00 → kr 175.00 | kr 259.20 | n/a | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 22.00 → CHF 20.00 | CHF 14.58 | n/a | 8 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €140.00 → €147.00 | €73.30 | n/a | 2 | Mar 12, 2025 |
Tecan Group AG
Sep 11, 2026
Reiterated: Hold
Price Target: CHF 160.00 → CHF 178.00
Current: CHF 247.60
Upside: -28.11%
bioMérieux S.A.
Sep 11, 2026
Reiterated: Sell
Price Target: €64.00 → €66.00
Current: €87.60
Upside: -24.66%
DiaSorin S.p.A.
Sep 11, 2026
Reiterated: Hold
Price Target: €60.00 → €71.00
Current: €77.50
Upside: -8.39%
Koninklijke Philips N.V.
Sep 11, 2026
Reiterated: Hold
Price Target: €25.00 → €22.00
Current: €22.72
Upside: -3.17%
Qiagen
Sep 11, 2026
Reiterated: Buy
Price Target: $45 → $47
Current: $46.17
Upside: +1.94%
Convatec Group PLC
Sep 2, 2026
Reiterated: Buy
Price Target: 270p → 289p
Current: 237p
Upside: +22.04%
Smith & Nephew plc
Sep 2, 2026
Downgraded: Hold
Price Target: 1,304p → 1,158p
Current: 1,088p
Upside: +6.43%
Fresenius SE & Co. KGaA
Aug 10, 2026
Reiterated: Buy
Price Target: €49.00 → €52.00
Current: €43.86
Upside: +18.57%
Fresenius Medical Care AG
Aug 5, 2026
Reiterated: Sell
Price Target: €32.00 → €31.00
Current: €39.46
Upside: -21.44%
Straumann Holding AG
Jun 30, 2026
Reiterated: Sell
Price Target: CHF 81.00 → CHF 85.00
Current: CHF 94.08
Upside: -9.65%
Jun 23, 2026
Upgraded: Hold
Price Target: CHF 172.00 → CHF 205.00
Current: CHF 274.20
Upside: -25.24%
Jun 23, 2026
Reiterated: Hold
Price Target: €41.00 → €37.00
Current: €40.85
Upside: -9.42%
Sep 9, 2025
Reiterated: Buy
Price Target: CHF 159.00 → CHF 161.00
Current: CHF 115.40
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: kr 182.00 → kr 175.00
Current: kr 259.20
Upside: n/a
Mar 18, 2025
Reiterated: Hold
Price Target: CHF 22.00 → CHF 20.00
Current: CHF 14.58
Upside: n/a
Mar 12, 2025
Reiterated: Hold
Price Target: €140.00 → €147.00
Current: €73.30
Upside: n/a